
### [MONDO:0001106](http://purl.obolibrary.org/obo/MONDO_0001106)
**Label:** kidney failure

**Subclasses:** [MONDO:0019799](http://purl.obolibrary.org/obo/MONDO_0019799) (hepatoerythropoietic porphyria), [MONDO:0015104](http://purl.obolibrary.org/obo/MONDO_0015104) (porphyria cutanea tarda), [MONDO:0019800](http://purl.obolibrary.org/obo/MONDO_0019800) (chronic hepatic porphyria), [MONDO:0008295](http://purl.obolibrary.org/obo/MONDO_0008295) (sporadic porphyria cutanea tarda), [MONDO:0008296](http://purl.obolibrary.org/obo/MONDO_0008296) (familial porphyria cutanea tarda), [MONDO:0019561](http://purl.obolibrary.org/obo/MONDO_0019561) (lupus erythematosus panniculitis), [MONDO:0006637](http://purl.obolibrary.org/obo/MONDO_0006637) (acute kidney tubular necrosis), [MONDO:0001110](http://purl.obolibrary.org/obo/MONDO_0001110) (chronic pyelonephritis), [MONDO:0007008](http://purl.obolibrary.org/obo/MONDO_0007008) (uremia), [MONDO:0001184](http://purl.obolibrary.org/obo/MONDO_0001184) (chronic rapidly progressive glomerulonephritis), [MONDO:0004375](http://purl.obolibrary.org/obo/MONDO_0004375) (end stage renal failure), [MONDO:0001382](http://purl.obolibrary.org/obo/MONDO_0001382) (hepatorenal syndrome), [MONDO:0005300](http://purl.obolibrary.org/obo/MONDO_0005300) (chronic kidney disease), [MONDO:0002492](http://purl.obolibrary.org/obo/MONDO_0002492) (acute kidney failure), [MONDO:0007022](http://purl.obolibrary.org/obo/MONDO_0007022) (xanthogranulomatous pyelonephritis), [MONDO:0003084](http://purl.obolibrary.org/obo/MONDO_0003084) (uremic neuropathy), 

**Mapped go classes:** [GO:0032092](http://purl.obolibrary.org/obo/GO_0032092) (positive regulation of protein binding), [GO:0006879](http://purl.obolibrary.org/obo/GO_0006879) (cellular iron ion homeostasis), [GO:0004853](http://purl.obolibrary.org/obo/GO_0004853) (uroporphyrinogen decarboxylase activity), [GO:0045177](http://purl.obolibrary.org/obo/GO_0045177) (apical part of cell), [GO:0045178](http://purl.obolibrary.org/obo/GO_0045178) (basal part of cell), [GO:0030509](http://purl.obolibrary.org/obo/GO_0030509) (BMP signaling pathway), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:2001186](http://purl.obolibrary.org/obo/GO_2001186) (negative regulation of CD8-positive, alpha-beta T cell activation), [GO:0008198](http://purl.obolibrary.org/obo/GO_0008198) (ferrous iron binding), [GO:0046502](http://purl.obolibrary.org/obo/GO_0046502) (uroporphyrinogen III metabolic process), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:2000008](http://purl.obolibrary.org/obo/GO_2000008) (regulation of protein localization to cell surface), [GO:0002725](http://purl.obolibrary.org/obo/GO_0002725) (negative regulation of T cell cytokine production), [GO:0010628](http://purl.obolibrary.org/obo/GO_0010628) (positive regulation of gene expression), [GO:1990459](http://purl.obolibrary.org/obo/GO_1990459) (transferrin receptor binding), [GO:0039706](http://purl.obolibrary.org/obo/GO_0039706) (co-receptor binding), [GO:0010862](http://purl.obolibrary.org/obo/GO_0010862) (positive regulation of pathway-restricted SMAD protein phosphorylation), [GO:0032435](http://purl.obolibrary.org/obo/GO_0032435) (negative regulation of proteasomal ubiquitin-dependent protein catabolic process), [GO:0055072](http://purl.obolibrary.org/obo/GO_0055072) (iron ion homeostasis), [GO:0060586](http://purl.obolibrary.org/obo/GO_0060586) (multicellular organismal iron ion homeostasis), [GO:1904434](http://purl.obolibrary.org/obo/GO_1904434) (positive regulation of ferrous iron binding), [GO:0090277](http://purl.obolibrary.org/obo/GO_0090277) (positive regulation of peptide hormone secretion), [GO:0009897](http://purl.obolibrary.org/obo/GO_0009897) (external side of plasma membrane), [GO:0006783](http://purl.obolibrary.org/obo/GO_0006783) (heme biosynthetic process), [GO:0016829](http://purl.obolibrary.org/obo/GO_0016829) (lyase activity), [GO:1904437](http://purl.obolibrary.org/obo/GO_1904437) (positive regulation of transferrin receptor binding), [GO:0006782](http://purl.obolibrary.org/obo/GO_0006782) (protoporphyrinogen IX biosynthetic process), [GO:0071281](http://purl.obolibrary.org/obo/GO_0071281) (cellular response to iron ion), [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm), [GO:0006778](http://purl.obolibrary.org/obo/GO_0006778) (porphyrin-containing compound metabolic process), [GO:0006811](http://purl.obolibrary.org/obo/GO_0006811) (ion transport), [GO:0005769](http://purl.obolibrary.org/obo/GO_0005769) (early endosome), [GO:0006779](http://purl.obolibrary.org/obo/GO_0006779) (porphyrin-containing compound biosynthetic process), [GO:0098711](http://purl.obolibrary.org/obo/GO_0098711) (iron ion import across plasma membrane), [GO:0010039](http://purl.obolibrary.org/obo/GO_0010039) (response to iron ion), [GO:0031410](http://purl.obolibrary.org/obo/GO_0031410) (cytoplasmic vesicle), [GO:0030881](http://purl.obolibrary.org/obo/GO_0030881) (beta-2-microglobulin binding), [GO:0048260](http://purl.obolibrary.org/obo/GO_0048260) (positive regulation of receptor-mediated endocytosis), [GO:0016831](http://purl.obolibrary.org/obo/GO_0016831) (carboxy-lyase activity), [GO:2000059](http://purl.obolibrary.org/obo/GO_2000059) (negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process), [GO:1904440](http://purl.obolibrary.org/obo/GO_1904440) (positive regulation of ferrous iron import across plasma membrane), [GO:2000273](http://purl.obolibrary.org/obo/GO_2000273) (positive regulation of receptor activity), [GO:1900122](http://purl.obolibrary.org/obo/GO_1900122) (positive regulation of receptor binding), [GO:2000272](http://purl.obolibrary.org/obo/GO_2000272) (negative regulation of receptor activity), [GO:1900121](http://purl.obolibrary.org/obo/GO_1900121) (negative regulation of receptor binding), [GO:0042168](http://purl.obolibrary.org/obo/GO_0042168) (heme metabolic process), [GO:0005102](http://purl.obolibrary.org/obo/GO_0005102) (receptor binding), [GO:0042446](http://purl.obolibrary.org/obo/GO_0042446) (hormone biosynthetic process), [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space), [GO:0048471](http://purl.obolibrary.org/obo/GO_0048471) (perinuclear region of cytoplasm), [GO:1990357](http://purl.obolibrary.org/obo/GO_1990357) (terminal web), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0002626](http://purl.obolibrary.org/obo/GO_0002626) (negative regulation of T cell antigen processing and presentation), [GO:1990712](http://purl.obolibrary.org/obo/GO_1990712) (HFE-transferrin receptor complex), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0055037](http://purl.obolibrary.org/obo/GO_0055037) (recycling endosome), [GO:1904283](http://purl.obolibrary.org/obo/GO_1904283) (negative regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I), 

**Class expressions from DL-Learner:**

- [GO:0002578](http://purl.obolibrary.org/obo/GO_0002578) (negative regulation of antigen processing and presentation) 55.26%
- [GO:0002577](http://purl.obolibrary.org/obo/GO_0002577) (regulation of antigen processing and presentation) and [GO:0048519](http://purl.obolibrary.org/obo/GO_0048519) (negative regulation of biological process) 55.26%
- [GO:0002577](http://purl.obolibrary.org/obo/GO_0002577) (regulation of antigen processing and presentation) and [GO:0002683](http://purl.obolibrary.org/obo/GO_0002683) (negative regulation of immune system process) 55.26%
- Thing 52.79%
- [GO:1990712](http://purl.obolibrary.org/obo/GO_1990712) (HFE-transferrin receptor complex) 52.63%
- [GO:1990459](http://purl.obolibrary.org/obo/GO_1990459) (transferrin receptor binding) 52.63%
- [GO:1990357](http://purl.obolibrary.org/obo/GO_1990357) (terminal web) 52.63%
- [GO:1904437](http://purl.obolibrary.org/obo/GO_1904437) (positive regulation of transferrin receptor binding) 52.63%
- [GO:1904435](http://purl.obolibrary.org/obo/GO_1904435) (regulation of transferrin receptor binding) 52.63%
- [GO:1904434](http://purl.obolibrary.org/obo/GO_1904434) (positive regulation of ferrous iron binding) 52.63%
- [GO:1904432](http://purl.obolibrary.org/obo/GO_1904432) (regulation of ferrous iron binding) 52.63%
- [GO:1904283](http://purl.obolibrary.org/obo/GO_1904283) (negative regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I) 52.63%
- [GO:1904282](http://purl.obolibrary.org/obo/GO_1904282) (regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I) 52.63%
- [GO:1900122](http://purl.obolibrary.org/obo/GO_1900122) (positive regulation of receptor binding) 52.63%
- [GO:0045178](http://purl.obolibrary.org/obo/GO_0045178) (basal part of cell) 52.63%


